Global Medical Cannabis Market, by Cancer, 2018-2027

Growth Outlook

• The 2027 portion of the Global Medical Cannabis Market, by Cancer, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 3519 Mn in 2026 and is projected to reach USD 4084 Mn by 2027 — a gain of about 16% over the forecast period, translating to a CAGR in the double digits.
• The use of medical cannabis for cancer treatment has been a topic of much debate and research in recent years. Global interest in this alternative form of medicine has been steadily increasing, with more and more countries legalizing its use for medical purposes.
• What the regional split looks like (2026): Americas leads, holding roughly 73% of segment value — the single largest regional share. Europe is the second-largest contributor. Asia-Pacific and Middle East & Africa make up the remainder, in descending order.
• By 2027, Americas alone is expected to reach USD 2870 Mn, with Europe at USD 901 Mn.

Market Dynamics

The use of medical cannabis for cancer treatment has been a topic of much debate and research in recent years. Global interest in this alternative form of medicine has been steadily increasing, with more and more countries legalizing its use for medical purposes. While the market size and growth rates of the global medical cannabis industry are important factors to consider, there are other aspects of its demand that are equally significant. Firstly, the increasing prevalence of cancer around the world has led to a rise in the demand for effective and accessible treatment options. Standard cancer treatments often come with significant side effects, and many patients are turning to medical cannabis as a more natural and potentially less harmful alternative. Medical cannabis has been found to help alleviate symptoms such as pain, nausea, and loss of appetite, which are common in cancer patients undergoing treatment. Furthermore, the growing body of scientific evidence supporting the use of medical cannabis as a complementary treatment for cancer has also fueled the demand for it. Studies have shown that certain compounds in cannabis, such as cannabinoids, can have anti-cancer properties and may even help inhibit the growth of tumors.

This has sparked interest from both medical professionals and patients alike, leading to an increase in demand for medical cannabis in the treatment of cancer. In addition to its potential benefits for cancer patients, the demand for medical cannabis is also driven by its availability and accessibility. As more countries legalise its use, the barriers to obtaining medical cannabis are reduced, making it easier for patients to access this form of treatment. This has been particularly beneficial for those living in areas with limited access to traditional cancer treatments, allowing them to explore alternative options. Another important factor contributing to the demand for medical cannabis in cancer treatment is the rising cost of conventional cancer treatments. The high costs associated with chemotherapy, radiation, and other standard treatments can be a significant burden for patients and their families. Medical cannabis, on the other hand, is often more affordable and can be a more cost-effective option for those seeking treatment for cancer. In summary, the demand for medical cannabis in the treatment of cancer is driven by a combination of factors, such as its potential benefits, increasing scientific evidence, availability, and cost-effectiveness.

While market size and growth rates are important for understanding the overall growth of the industry, it is crucial to also consider the demand for medical cannabis in specific medical conditions, such as cancer. As more research is conducted and its effectiveness is further validated, the demand for medical cannabis in cancer treatment is expected to continue to rise.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2024.